Tenzer S - Search Results

1

Epitope length variants balance protective immune responses and viral escape in HIV-1 infection.

Pymm P, Tenzer S, Wee E, Weimershaus M, Burgevin A, Kollnberger S, Gerstoft J, Josephs TM, Ladell K, McLaren JE, Appay V, Price DA, Fugger L, Bell JI, Schild H, van Endert P, Harkiolaki M, Iversen AKN. Pymm P, et al. Among authors: tenzer s. Cell Rep. 2022 Mar 1;38(9):110449. doi: 10.1016/j.celrep.2022.110449. Cell Rep. 2022. PMID: 35235807 Free PMC article.

2

Using the World Wide Web for predicting CTL epitopes.

Nussbaum AK, Kuttler C, Tenzer S, Schild H. Nussbaum AK, et al. Among authors: tenzer s. Curr Opin Immunol. 2003 Feb;15(1):69-74. doi: 10.1016/s0952791502000043. Curr Opin Immunol. 2003. PMID: 12495736 Review. No abstract available.

3

A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation.

Hebart H, Rauser G, Stevanovic S, Haenle C, Nussbaum AK, Meisner C, Bissinger AL, Tenzer S, Jahn G, Loeffler J, Rammensee HG, Schild H, Einsele H. Hebart H, et al. Among authors: tenzer s. Exp Hematol. 2003 Oct;31(10):966-73. doi: 10.1016/s0301-472x(03)00203-0. Exp Hematol. 2003. PMID: 14550813 Free article.

4

Quantitative analysis of prion-protein degradation by constitutive and immuno-20S proteasomes indicates differences correlated with disease susceptibility.

Tenzer S, Stoltze L, Schönfisch B, Dengjel J, Müller M, Stevanović S, Rammensee HG, Schild H. Tenzer S, et al. J Immunol. 2004 Jan 15;172(2):1083-91. doi: 10.4049/jimmunol.172.2.1083. J Immunol. 2004. PMID: 14707082

5

Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding.

Tenzer S, Peters B, Bulik S, Schoor O, Lemmel C, Schatz MM, Kloetzel PM, Rammensee HG, Schild H, Holzhütter HG. Tenzer S, et al. Cell Mol Life Sci. 2005 May;62(9):1025-37. doi: 10.1007/s00018-005-4528-2. Cell Mol Life Sci. 2005. PMID: 15868101

6

Assays of proteasome-dependent cleavage products.

Tenzer S, Schild H. Tenzer S, et al. Methods Mol Biol. 2005;301:97-115. doi: 10.1385/1-59259-895-1:097. Methods Mol Biol. 2005. PMID: 15917629

7

Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses.

Osterloh P, Linkemann K, Tenzer S, Rammensee HG, Radsak MP, Busch DH, Schild H. Osterloh P, et al. Among authors: tenzer s. Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5042-7. doi: 10.1073/pnas.0509256103. Epub 2006 Mar 20. Proc Natl Acad Sci U S A. 2006. PMID: 16549793 Free PMC article.

8

Herpes virus entry mediator synergizes with Toll-like receptor mediated neutrophil inflammatory responses.

Haselmayer P, Tenzer S, Kwon BS, Jung G, Schild H, Radsak MP. Haselmayer P, et al. Among authors: tenzer s. Immunology. 2006 Nov;119(3):404-11. doi: 10.1111/j.1365-2567.2006.02449.x. Immunology. 2006. PMID: 17067315 Free PMC article.

9

Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1.

Asemissen AM, Keilholz U, Tenzer S, Müller M, Walter S, Stevanovic S, Schild H, Letsch A, Thiel E, Rammensee HG, Scheibenbogen C. Asemissen AM, et al. Among authors: tenzer s. Clin Cancer Res. 2006 Dec 15;12(24):7476-82. doi: 10.1158/1078-0432.CCR-06-1337. Clin Cancer Res. 2006. PMID: 17189421

10

Characterizing the N-terminal processing motif of MHC class I ligands.

Schatz MM, Peters B, Akkad N, Ullrich N, Martinez AN, Carroll O, Bulik S, Rammensee HG, van Endert P, Holzhütter HG, Tenzer S, Schild H. Schatz MM, et al. Among authors: tenzer s. J Immunol. 2008 Mar 1;180(5):3210-7. doi: 10.4049/jimmunol.180.5.3210. J Immunol. 2008. PMID: 18292545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page